Diffuse large B-cell non-Hodgkin lymphoma in the very elderly: challenges and solutions

Area of Science:

• Oncology
• Geriatric Medicine
• Hematology

Background:

• Diffuse large B-cell lymphoma (DLBCL) predominantly affects the elderly.
• Current treatment guidelines are based on younger patient cohorts, necessitating age-specific strategies.
• The aging global population, particularly those over 80, highlights the need for optimized DLBCL management.

Purpose of the Study:

• To address the treatment challenges of DLBCL in patients over 80.
• To define "elderly" in the context of DLBCL and identify assessment difficulties.
• To provide a treatment algorithm for clinicians managing DLBCL in octogenarians.

Main Methods:

• Review of pivotal clinical studies focusing on elderly DLBCL patients.
• Analysis of challenges in assessing and treating older adults with DLBCL.
• Development of a clinical decision-making algorithm.

Main Results:

• Current DLBCL treatment paradigms are not optimized for elderly populations.
• Specific challenges exist in assessing comorbidities and treatment tolerance in patients over 80.
• Existing literature provides a basis for age-adapted treatment approaches.

Conclusions:

• Optimizing DLBCL treatment for patients over 80 is crucial for improving survival outcomes.
• A defined algorithm can assist clinicians in making informed treatment decisions for elderly DLBCL patients.
• Further research is needed to refine age-specific DLBCL therapies.